ComplianceOnline

Do You Really Need To Do A Recall? If So, What Is Required?

Instructor: Cheryl Wagoner
Product ID: 703895
  • Duration: 60 Min

recorded version

$229.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

$399.00
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This training program will provide practical pointers on documenting the recall decision. Recall can be a very costly process for a manufacturer. It is really important from a regulatory perspective to properly document the decision process whether a recall is necessary or not. The new guidance can help provide some direction in making the decision. Though guidance documents are not binding, they do tend to reflect the current thinking of the FDA. Beyond the guidance, the webinar will also illustrate best practices for documenting the recall process in the event that you determine a recall is warranted.

Why Should You Attend:

In October 2014, FDA published a new guidance entitled "Distinguishing Medical Device Recalls from Medical Device Enhancements". This guidance is intended to:

  • Clarify when a change to a device constitutes a medical device recall
  • Distinguish those instances from device enhancements that do not meet the definition of a medical device recall
  • Clarify reporting requirements under 21 CFR §806

The guidance should not be used alone but instead should be applied in conjunction with 21 CFR §806 and if applicable, 21 CFR §7, subpart c. This webinar will discuss the primary points of the new guidance, review 21 CFR §806 and i21 CFR §7, subpart c, as well as how to document your recall decision and what is needed if a recall is warranted.

Areas Covered in the Webinar:

  • Background of the new guidance
  • 21 CFR §806
  • 21 CFR §7, subpart c
  • When is a change a recall?
  • When is a change not a recall?
  • Examples
  • Documenting the decision
  • Documenting the recall process
  • Q&A

Who Will Benefit:

This webinar will provide valuable assistance to all personnel in:

  • Regulatory roles
  • Quality assurance management
  • Manufacturing management responsible for executing recall activities
  • Project managers and staff involved with recalls

Instructor Profile:

Cheryl Wagoner has 20 years of experience in quality assurance, and regulatory affairs. She is currently the principal consultant/owner of Wagoner Consulting LLC, where she provides consulting services to medical device and pharmaceutical companies. Previously, she has held various positions in quality, regulatory, clinical and compliance in the medical device and pharmaceutical industries.

Ms. Wagoner is a member of Regulatory Affairs Professionals (RAPS) and Medical Device Manufacturers (MDMA) FDA Working Group. She completed the RAPS Executive Development Program at the Kellogg School of Management.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading